Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 101–200 of 1,001
Connor, T. J., Starr, N., O'Sullivan, J. B., & Harkin, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.007 · Cited by 215
Réus, G. Z., Jansen, K., Titus, S., Carvalho, A. F., Gabbay, V., & Quevedo, J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.007 · Cited by 221
“Pre-treatment with etanercept, a TNF-α antagonist, partially diminished BCG-induced IDO activation and depressive-like behavior (O’Connor et al., 2009a).”
BackgroundNeuropsychiatric Disease and Toxoplasma gondii Infection
Henriquez, S. A., Brett, R., Alexander, J., Pratt, J., & Roberts, C. W. (2009) · Neuroimmunomodulation · doi:10.1159/000180267 · Cited by 206
Zhang, J., Ma, L., Chang, L., Pu, Y., Qu, Y., & Hashimoto, K. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00878-3 · Cited by 208
Ohgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 207
“This finding is in agreement with previous reports (Kang et al., 2011; O'Connor et al., 2009).”
InfluentialFelger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
“…in DA release is consistent with literature in rodents whereby increased monoamines and metabolites have often been observed regionally following acute or sub-chronic exposure to peripheral immune challenge or inflammatory cytokines (Dunn, 2006; Felger and Miller, 2012; O’Connor et al, 2009).”
BackgroundMiyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.002 · Cited by 212
Walker, A. K., Wing, E. E., Banks, W. A., & Dantzer, R. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0076-7 · Cited by 205
Self-citationO'Donovan, A., Rush, G., Hoatam, G., Hughes, B. M., McCrohan, A., Kelleher, C., O'Farrelly, C., & Malone, K. M. (2013) · Depression and Anxiety · doi:10.1002/da.22087 · Cited by 210
Kuhlman, K. R., Chiang, J. J., Horn, S., & Bower, J. E. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.020 · Cited by 208
Ma, K., Zhang, H., & Baloch, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050733 · Cited by 205
Corona, A. W., Huang, Y., O'Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., & Godbout, J. P. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-93 · Cited by 200
Self-citationImmunopsychiatry: important facts
Khandaker, G. M., Dantzer, R., & Jones, P. B. (2017) · Psychological Medicine · doi:10.1017/s0033291717000745 · Cited by 183
Self-citationNeuroinflammatory Dynamics Underlie Memory Impairments after Repeated Social Defeat
McKim, D. B., Niraula, A., Tarr, A. J., Wohleb, E. S., Sheridan, J. F., & Godbout, J. P. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2394-15.2016 · Cited by 204
“Indeed, increased neuroinflammatory signaling augments neurobiological processes implicated in behavioral disorders involving neurogenesis (Koo and Duman, 2008) and metabolism of neurotransmitters (Miller et al., 2009; O’Connor et al., 2009).”
BackgroundMartin-Subero, M., Anderson, G., Kanchanatawan, B., Berk, M., & Maes, M. (2016) · CNS Spectrums · doi:10.1017/s1092852915000449 · Cited by 196
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
“Interestingly, the blockage of IDO reduces depressive symptoms without reducing sickness behaviour [352,353], which suggests that IDO is responsible for transformation from sickness behaviour to inflammation-induced depression.”
BackgroundFerreira Mello, B. S., Monte, A. S., McIntyre, R. S., Soczynska, J. K., Custódio, C. S., Cordeiro, R. C., Chaves, J. H., Mendes Vasconcelos, S. M., Nobre Júnior, H. V., Florenço de Sousa, F. C., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.008 · Cited by 195
“Importantly, minocycline (50 mg/kg) attenuates LPS-induced depressive-like behavior at a time sickness behavior is no longer present (O’Connor et al., 2009).”
BackgroundResultThe interplay between stress, inflammation, and emotional attention: relevance for depression
Maydych, V. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00384 · Cited by 193
Novel therapeutic targets in depression: Minocycline as a candidate treatment
Soczynska, J. K., Mansur, R. B., Brietzke, E., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 189
Mithaiwala, M. N., Santana-Coelho, D., Porter, G. A., & O’Connor, J. C. (2021) · Cells · doi:10.3390/cells10061548 · Cited by 190
“The activation of KP is associated with depressive and anxiety like behaviors in animal models [52].”
BackgroundSelf-citationRodent models in depression research: Classical strategies and new directions
Pollak, D. D., Rey, C. E., & Monje, F. J. (2010) · Annals of Medicine · doi:10.3109/07853891003769957 · Cited by 187
Castanon, N., Luheshi, G., & Layé, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00229 · Cited by 181
Self-citationFujigaki, H., Yamamoto, Y., & Saito, K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.011 · Cited by 178
“Indeed, preclinical studies using rodent have indicated that depressive-like behaviors induced by immune activation using LPS and bacillus CalmetteeGu erin (BCG) are mediated by IDO1 activation (O'Connor et al., 2009a; O'Connor et al., 2009b).”
Depression, dementia and immune dysregulation
Hayley, S., Hakim, A. M., & Albert, P. R. (2021) · Brain · doi:10.1093/brain/awaa405 · Cited by 186
“LPS) provoked depressive-like sickness behaviours observed in rodents (Dantzer et al., 2008; O’Connor et al., 2009).”
BackgroundHaase, J., & Brown, E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.002 · Cited by 175
Zhu, H.-Z., Liang, Y.-D., Ma, Q.-Y., Hao, W.-Z., Li, X.-J., Wu, M.-S., Deng, L.-J., Li, Y.-M., & Chen, J.-X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108621 · Cited by 188
Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
Porter, G. A., & O’Connor, J. C. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i1.77 · Cited by 178
Self-citationRole of Adiposity-Driven Inflammation in Depressive Morbidity
Capuron, L., Lasselin, J., & Castanon, N. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.123 · Cited by 182
“This enzyme is the first and ratelimiting enzyme degrading tryptophan, the essential aminoacid precursor of serotonin, along the kynurenine pathway (Dantzer et al, 2008; O'Connor et al, 2009b; O'Connor et al, 2009c).”
BackgroundSelf-citationHuffman, W. J., Subramaniyan, S., Rodriguiz, R. M., Wetsel, W. C., Grill, W. M., & Terrando, N. (2019) · Brain Stimulation · doi:10.1016/j.brs.2018.10.005 · Cited by 181
“Aside from microglia activation and inflammatory responses, we investigated whether pVNS could exert any effects on LPS-induced cognitive impairment using a variety of tests as has been reported by other investigators [41-43].”
Moreau, M., André, C., O’Connor, J. C., Dumich, S. A., Woods, J. A., Kelley, K. W., Dantzer, R., Lestage, J., & Castanon, N. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.04.001 · Cited by 169
Self-citationRodent Models of Depression: Neurotrophic and Neuroinflammatory Biomarkers
Stepanichev, M., Dygalo, N. N., Grigoryan, G., Shishkina, G. T., & Gulyaeva, N. (2014) · BioMed Research International · doi:10.1155/2014/932757 · Cited by 169
“It has been shown that intraperitoneal administration of LPS increased immobility in the FST and this effect prevented by minocycline administration [161, 162].”
BackgroundAddressing the tuberculosis–depression syndemic to end the tuberculosis epidemic
Sweetland, A. C., Kritski, A., Oquendo, M. A., Sublette, M. E., Norcini Pala, A., Silva, L. R. B., Karpati, A., Silva, E. C., Moraes, M. O., Silva, J. R. L. E., et al. (2017) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.16.0584 · Cited by 177
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Schwarcz, R., Guidetti, P., Sathyasaikumar, K. V., & Muchowski, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.005 · Cited by 176
“Moreover, endogenous agents such as steroid hormones and cytokines were found to stimulate the activity of individual KP enzymes and may therefore have distinct effects on the function of neuroactive KP metabolites (Andre et al., 2008; Heyes et al., 1997; O’Connor et al., 2008; Oxenkrug, 2007).”
BackgroundFelger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
“…and intra-assay variability were reliably ~12% and assay sensitivity was .04 pg/mL. DA, HVA, and DOPAC were measured in duplicate 20 μL CSF aliquots using high-performance liquid chromatography (HPLC) as described (O’Connor et al. 2008) using an ESA Model 530 Fluorescence detector at +320 mV.”
Dooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176
Meier, T. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Morris, H. M., Victor, T. A., Bodurka, J., Teague, T. K., Dantzer, R., & Savitz, J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.003 · Cited by 175
Self-citationInflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer
Lanser, L., Kink, P., Egger, E. M., Willenbacher, W., Fuchs, D., Weiss, G., & Kurz, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00249 · Cited by 169
Parrott, J. M., Redus, L., Santana-Coelho, D., Morales, J., Gao, X., & O'Connor, J. C. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.200 · Cited by 174
Self-citationThe role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
Woelfer, M., Kasties, V., Kahlfuss, S., & Walter, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.034 · Cited by 171
Dellarole, A., Morton, P., Brambilla, R., Walters, W., Summers, S., Bernardes, D., Grilli, M., & Bethea, J. R. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.003 · Cited by 165
“…in patients affected by major depression (Dantzer et al., 2008; Miller et al., 2009), while in rodents administration of cytokines such as TNF induces a mood disturbance known as ‘‘sickness behavior’’, which shares many symptoms of major depression (Anisman et al., 2002; O’Connor et al., 2009a,b).”
Burke, N. N., Kerr, D. M., Moriarty, O., Finn, D. P., & Roche, M. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.06.015 · Cited by 169
Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research
Nguyen, N. T., Nakahama, T., Le, D. H., Van Son, L., Chu, H. H., & Kishimoto, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00551 · Cited by 163
O'Farrell, K., & Harkin, A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.004 · Cited by 164
“Similarly, IDO activation has been shown to mediate LPS-driven depressive-like behaviours in rodents, with these behaviours being abolished by use of the IDO inhibitor, 1-methyl tryptophan (L) (O'Connor et al., 2009; Lawson et al., 2013).”
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Remus, J. L., & Dantzer, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw028 · Cited by 164
“This review will discuss the current state of research on inflammation-induced depression, what is known about the mechanisms, and possible novel targets for the treatment of inflammation-induced depression.”
BackgroundSelf-citationKynurenine pathway metabolites and suicidality
Bryleva, E. Y., & Brundin, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.034 · Cited by 168
“are mediated by NMDAR activation, likely caused by the increased production of QUIN (O'Connor et al., 2009; Walker et al., 2013).”
Neuropsychiatric Comorbidity in Obesity: Role of Inflammatory Processes
Castanon, N., Lasselin, J., & Capuron, L. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00074 · Cited by 161
Self-citationTranslational approaches to treatment-induced symptoms in cancer patients
Dantzer, R., Meagher, M. W., & Cleeland, C. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.88 · Cited by 161
Self-citationLawson, M. A., Parrott, J. M., McCusker, R. H., Dantzer, R., Kelley, K. W., & O’Connor, J. C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-87 · Cited by 161
“Noteworthy is our previous demonstration that cytokine expression in IDO1 KO mice is not different from that of WT mice following peripheral LPS [7].”
Self-citationLasselin, J., Schedlowski, M., Karshikoff, B., Engler, H., Lekander, M., & Konsman, J. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.001 · Cited by 165
“In addition, depressive-like behavior in rodents appears to relate to changes in serotonin biosynthesis (O’Connor et al., 2009) and CNS transporters (Zhu et al.”
Toll-like receptor signaling and stages of addiction
Crews, F. T., Walter, T. J., Coleman, L. G., & Vetreno, R. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4560-6 · Cited by 156
“microglial activation and the development of depressionlike behavior (O’Connor et al. 2009).”
Klawonn, A. M., Fritz, M., Castany, S., Pignatelli, M., Canal, C., Similä, F., Tejeda, H. A., Levinsson, J., Jaarola, M., Jakobsson, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.016 · Cited by 167
Zhang, H.-Y., Wang, Y., He, Y., Wang, T., Huang, X.-H., Zhao, C.-M., Zhang, L., Li, S.-W., Wang, C., Qu, Y.-N., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01871-9 · Cited by 161
Golia, M. T., Poggini, S., Alboni, S., Garofalo, S., Ciano Albanese, N., Viglione, A., Ajmone-Cat, M. A., St-Pierre, A., Brunello, N., Limatola, C., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.003 · Cited by 155
Valladares, R., Bojilova, L., Potts, A. H., Cameron, E., Gardner, C., Lorca, G., & Gonzalez, C. F. (2013) · The FASEB Journal · doi:10.1096/fj.12-223339 · Cited by 158
“The kynurenine:tryptophan (K:T) ratio (product:substrate) is a reliable indicator of IDO enzymatic activity (30, 31).”
BackgroundPark, S.-E., Dantzer, R., Kelley, K. W., & McCusker, R. H. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-12 · Cited by 158
Self-citationHaapakoski, R., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.012 · Cited by 157
“Since peripheral L-KYN and 3-hydroxy-L-kynurenine (3-HK) can enter the CNS via the blood brain barrier (Vecsei et al., 2013), central and/or peripheral activation of IDO and the formation of neurotoxic catabolites in response to increased inflammatory activity may account for the adverse innate and adaptive immune eff…”
BackgroundGarrison, A. M., Parrott, J. M., Tuñon, A., Delgado, J., Redus, L., & O’Connor, J. C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.019 · Cited by 150
“Moreover, preclinical rodent studies have found that IDO is necessary for mice to develop depressive-like behaviors in response to inflammation and KMO is required for this anhedonic response (O'Connor et al., 2009; Parrott et al., 2016).”
BackgroundSelf-citationCorona, A. W., Norden, D. M., Skendelas, J. P., Huang, Y., O’Connor, J. C., Lawson, M., Dantzer, R., Kelley, K. W., & Godbout, J. P. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.008 · Cited by 152
Self-citationInnate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases
García‐Bueno, B., Caso, J. R., Madrigal, J. L. M., & Leza, J. C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.013 · Cited by 171
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Erickson, M. A., Rhea, E. M., Knopp, R. C., & Banks, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052681 · Cited by 165
“Inflammationrelated depressive-like behaviors, which can persist after sickness behaviors resolve [93], depend in part on overproduction and transport of kynurenine across the BBB [94].”
BackgroundHuman sickness behavior: Ultimate and proximate explanations
Shattuck, E. C., & Muehlenbein, M. P. (2015) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22698 · Cited by 145
Microglial dysfunction connects depression and Alzheimer’s disease
Santos, L. E., Beckman, D., & Ferreira, S. T. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.011 · Cited by 154
Husain, M. I., Chaudhry, I. B., Husain, N., Khoso, A. B., Rahman, R. R., Hamirani, M. M., Hodsoll, J., Qurashi, I., Deakin, J. F., & Young, A. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117724352 · Cited by 144
“Pro-inflammatory cytokines can activate the enzyme indoleamine 2,3-dioxygenase (IDO).”
BackgroundLopresti, A. L., Hood, S. D., & Drummond, P. D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458732 · Cited by 151
“LPSs are also able to activate IDO production leading to increased kynurenine metabolites and tryptophan breakdown (O’Connor et al., 2009; Fu et al., 2010; Dobos et al., 2012).”
BackgroundLiu, W., Sheng, H., Xu, Y., Liu, Y., Lu, J., & Ni, X. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.041 · Cited by 170
Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
Suneson, K., Lindahl, J., Hårsmar, S. C., Söderberg, G., & Lindqvist, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041640 · Cited by 160
“showed, in a mice model of depression, that activation of IDO occurs in parallel to the development of depressive-like behavior after peripheral LPS-injections [60].”
BackgroundLi, W., Ali, T., Zheng, C., Liu, Z., He, K., Shah, F. A., Ren, Q., Rahman, S. U., Li, N., Yu, Z.-J., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02091-5 · Cited by 145
Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders
Kelley, K. W., & Dantzer, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.12.013 · Cited by 141
Self-citationLai, Y., Liu, C.-W., Yang, Y., Hsiao, Y.-C., Ru, H., & Lu, K. (2021) · Nature Communications · doi:10.1038/s41467-021-26209-8 · Cited by 145
Savitz, J., Frank, M. B., Victor, T., Bebak, M., Marino, J. H., Bellgowan, P. S. F., McKinney, B. A., Bodurka, J., Kent Teague, T., & Drevets, W. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.007 · Cited by 146
Muscatell, K. A., Moieni, M., Inagaki, T. K., Dutcher, J. M., Jevtic, I., Breen, E. C., Irwin, M. R., & Eisenberger, N. I. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.022 · Cited by 146
“One possibility that has received some attention in the animal literature suggests that exposure to endotoxin activates indoleamine 2,3-dioxygenase (IDO), an enzyme that is induced by pro-inflammatory cytokines and is important for the degradation of tryptophan, the primary aminoacid precursor of serotonin (O’Connor e…”
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
Dantzer, R., & Walker, A. K. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1187-1 · Cited by 136
Self-citationThe homeostatic role of neuropeptide Yin immune function and its impact on mood and behaviour
Farzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145
“…response (sedation, social withdrawal, anorexia) is followed by signs of depression-like behaviour which has been demonstrated to be mediated by activation of the enzyme indoleamine-2,3-dioxygenase by pro-inflammatory cytokines, leading to the production of kynurenine (O’Connor et al. 2009).”
BackgroundSmall talk: microbial metabolites involved in the signaling from microbiota to brain
Caspani, G., & Swann, J. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.08.001 · Cited by 138
Inflammation in depression: is adiposity a cause?
C. Shelton, R., & H. Miller, A. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 141
“Interestingly, peripheral administration of the cytokine-inducer, lipopolysaccharide (LPS) to mice activates IDO and is associated with depressive-like behavior.(36) These LPS-induced behavioral changes can be reversed by IDO inhibition using the IDO antagonist 1-methyltryptophan.”
The importance of cytokines and autoantibodies in depression
Postal, M., & Appenzeller, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.09.001 · Cited by 154
Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
Hashimoto, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047796 · Cited by 137
Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy
Paudel, Y. N., Shaikh, M. F., Shah, S. Z., Kumari, Y., & Othman, I. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.020 · Cited by 152
Exercise, inflammation, and fatigue in cancer survivors
LaVoy, E. C. P., Fagundes, C. P., & Dantzer, R. (2026) · PubMed · doi:10.22029/eir.2016.1710 · Cited by 138
Self-citationHu, P., Lü, Y., Pan, B., & Zhang, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911076 · Cited by 152
Fu, X., Zunich, S. M., O'Connor, J. C., Kavelaars, A., Dantzer, R., & Kelley, K. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-43 · Cited by 130
Self-citationZheng, S., Yu, M., Lu, X., Huo, T., Ge, L., Yang, J., Wu, C., & Li, F. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.11.003 · Cited by 144
The Microbiome-Gut-Brain Axis and Resilience to Developing Anxiety or Depression under Stress
Bear, T., Dalziel, J., Coad, J., Roy, N., Butts, C., & Gopal, P. (2021) · Microorganisms · doi:10.3390/microorganisms9040723 · Cited by 126
Ortega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Martinez-Rozas, L., Rodríguez–Jiménez, R., Álvarez‐Mon, M., & Lahera, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01964-w · Cited by 151
“Importantly, the increased IDO activity is a crucial mechanism related to the in fl ammation-induced depressive-like behavior by endotoxemia [233], thus showing the relevance that gut dysbiosis and bacterial translocation may have on BD patients.”
BackgroundFuertig, R., Azzinnari, D., Bergamini, G., Cathomas, F., Sigrist, H., Seifritz, E., Vavassori, S., Luippold, A., Hengerer, B., Ceci, A., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.020 · Cited by 135
“After induction of high plasma KYN by lipopolysaccharide (LPS, 1 mg/kg i.p.), which up‐regulates Ido1 expression (O'Connor et al., 2009b), at 24 h previously, 200 mg/kg p.o. IDOInh led to complete reversal of the increase in plasma KYN at 1 h post‐administration; …”
The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies
Garcia, P., Wang, Y., Viallet, J. P., & Jílková, Z. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791081 · Cited by 153
“For instance, injecting lipopolysaccharide (LPS), one of the most used modulators to induce inflammation, can have a dramatic impact on mice, with the appearance of depressive-like behaviors (6) and neurological damage (7).”
BackgroundCell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Morris, G., Walker, A. J., Berk, M., Maes, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0793-y · Cited by 132
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Doney, E., Cadoret, A., Dion‐Albert, L., Lebel, M., & Ménard, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15239 · Cited by 151
“Reflecting this effect, peripheral lkynurenine administration induced depressivelike behavior in a dosedependent manner (O'Connor et al., 2009).”
BackgroundDebnath, S., Velagapudi, C., Redus, L., Thameem, F., Kasinath, B. S., Hura, C., Lorenzo, C., Abboud, H. E., & O’Connor, J. C. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917694600 · Cited by 144
Self-citationAcharjee, S., Nayani, N., Tsutsui, M., Hill, M. N., Ousman, S. S., & Pittman, Q. J. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.07.003 · Cited by 138
Ortega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Guijarro, L. G., Lahera, G., Monserrat, J., Valls, P., Mora, F., Rodríguez-Jiménez, R., et al. (2022) · Metabolites · doi:10.3390/metabo12010050 · Cited by 123
Zhang, W.-Y., Guo, Y.-J., Han, W.-X., Yang, M.-Q., Wen, L.-P., Wang, K.-Y., & Jiang, P. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.012 · Cited by 123
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marszałek‐Grabska, M., Walczak, K., Gaweł, K., Wicha-Komsta, K., Wnorowska, S., Wnorowski, A., & Turski, W. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107845 · Cited by 136
The etiology of poststroke-depression: a hypothesis involving HPA axis
Zhou, L., Wang, T., Yu, Y., Li, M., Sun, X., Song, W., Wang, Y., Zhang, C., & Fu, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113146 · Cited by 142
Kiank, C., Zeden, J.-P., Drude, S., Domanska, G., Fusch, G., Otten, W., & Schuett, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011825 · Cited by 124
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice
Kaczmarczyk, M. M., Machaj, A. S., Chiu, G. S., Lawson, M. A., Gainey, S. J., York, J. M., Meling, D. D., Martin, S. A., Kwakwa, K. A., Newman, A. F., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.01.004 · Cited by 141
“IDO KO mice are resistant to inflammation-induced adverse behaviors (O’Connor et al., 2009a).”
InfluentialSelf-citationStimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder
Spijker, S., Van Zanten, J. S., De Jong, S., Penninx, B. W. J. H., van Dyck, R., Zitman, F. G., Smit, J. H., Ylstra, B., Smit, A. B., & Hoogendijk, W. J. G. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.017 · Cited by 111
Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
Borsini, A., Alboni, S., Horowitz, M. A., Tojo, L. M., Cannazza, G., Su, K.-P., Pariante, C. M., & Zunszain, P. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.006 · Cited by 126
Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
Parrott, J. M., & O’Connor, J. C. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00116 · Cited by 123
“Recent clinical and preclinical data, within the context of inflammation, indicate that the brain is able to compensate for reduced peripheral tryptophan levels leaving central serotonin levels unaffected (11, 12).”
BackgroundSelf-citationThe Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
Dobos, N., de Vries, E. F. J., Kema, I. P., Patas, K., Prins, M., Nijholt, I. M., Dierckx, R. A., Korf, J., den Boer, J. A., Luiten, P. G. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111097 · Cited by 118
“This may explain the “paradox” of decreased behavioral activity but increased [50] or unchanged [22] serotonergic neurotransmission following acute immune stimulation.”
BackgroundMethodResultInfluential
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.